Please login to the form below
Biogen
This page shows the latest Biogen news and features for those working in and with pharma, biotech and healthcare.
Orphan drugs from Biogen and Amicus win UK Prix Galien
Orphan drugs from Biogen and Amicus win UK Prix Galien. Amicus’Galafold and Biogen’s Spinraza have won the two top prizes at the UK Prix Galien, the biennial awards which ... Biogen receive their award for Spinraza. In the dedicated orphan drug
Latest news
-
After mixed signals, will Eisai and Biogen press on with Alzheimer’s hopeful?
After mixed signals, will Eisai and Biogen press on with Alzheimer’ s hopeful? ... Eisai and Biogen have yet to confirm if they will proceed into phase 3 trials, though this still looks likely.
-
Spinraza lifts Biogen ahead of Alzheimer’s data
There were also a pair of setbacks in Biogen’s R&D portfolio, which mean the company will have to lean more heavily in Spinraza for a while. ... Biogen gave nothing away on the call, but will host live webcasts of the proceedings.
-
First Humira biosimilars reach EU market
Copycat versions of the TNF inhibitor from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’Sandoz unit are starting to become available in their first EU markets now that ... Also already launched is Samsung Bioepis and
-
Roche gets wider approval for haemophilia drug Hemlibra
Adynovate, Biogen’s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla – with the advantage of being dosed every one, two, or four weeks depending on need, rather than multiple times
-
Roche drug hits the mark in spinal muscular atrophy studies
If all goes according to plan the drug could became an oral alternative to Biogen’s injectable Spinraza (nusinersen), the first and only approved therapy for SMA which has been available
More from news
Approximately 97 fully matching, plus 278 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
Samsung Bioepis is a joint venture between Samsung and Biogen Idec; the latter recently (June 2018) invested $700m to bring its stake in the jv to 49.9%.
-
No incentive for a cure
to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.
-
Deal Watch January 2018
Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... Option, licence. 223. Karyopharm Therapeutics/ Biogen. Oral SINE compound
-
The good, the bad and the ugly
Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue, ”says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Biogen also has Aducanumab in the pipeline, which is forecast to generate huge sales
-
Simplifying HCP access to digital information
Biogen, one of Align Biopharma’s founding members. ... Other founding members include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis and Pfizer.
More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.
Latest appointments
-
BMS appoints CCO, Stephen Davies joins Eisai and more
operations. She joins Sobi from Biogen, where she served as vice president for global supply chain operations and strategic partnerships.
-
Biogen appoints executive VP, corporate development
Biogen has appointed Daniel Karp as its executive vice president, corporate development effective 11 June. ... He said: “It's a privilege to join Biogen, a true leader in neuroscience," Karp said.
-
Gamida Cell strengthens leadership team
Nee will lead market research, analytics, forecasting, commercial strategies and competitive intelligence at the company, activities he has experience with following his time with Biogen, Amgen and Novartis.
-
Editas Medicine names James Mullen as chairman
Before joining Patheon, Mullen served as chief executive officer and president at Biogen and before this he held numerous roles at the biotech.
-
Acumen appoints new strategy director
Thomas Bols will focus on reinforcing Acumen’s healthcare practice
More from appointments
Approximately 16 fully matching, plus 32 partially matching documents found.
Latest from PMHub
-
Antisense Oligonucleotides Market Intelligence and Analysis for Period (2017-2027)
Antisense Oligonucleotides Market: Key Players. Some of the players identified in the global antisense oligonucleotides market include Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics
-
Autoimmune Disease Therapeutics Market is Set to Experience Revolutionary Growth by 2026
Hoffmann-La Roche AG, Merck &Co. Inc., Bayer Schering Pharma AG, Johnson &Johnson Inc., Biogen Idec Inc., GlaxoSmithKline Plc, Squibb Company, Elan Corporation Plc, Eli Lilly and Company, Chugai Pharmaceutical Co.
-
Leukemia Therapeutics Treatment Market Revenue, Opportunity, Segment and Key Trends 2015 - 2025
Request to View TOC@ . Major market playerscontributing the global market share of leukemia therapeutics treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals, Inc., Biogen Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers Squibb,
-
Sales of Autoimmune Disease Therapeutics Market to Witness a Decline By the End of 2026
Hoffmann-La Roche AG, Merck &Co. Inc., Bayer Schering Pharma AG, Johnson &Johnson Inc., Biogen Idec Inc., GlaxoSmithKline Plc, Squibb Company, Elan Corporation Plc, Eli Lilly and Company, Chugai Pharmaceutical Co.
-
Pegasus shortlisted for four PM Society Digital Media Awards 2016
four awards at the PM Society Digital Media Awards 2016 for its ‘ MS Explorer’ exhibit stand installation for Biogen, and 'Beatbox Cough' campaign for Boehringer Ingelheim and the Roy Castle Lung ... As a leader in multiple sclerosis (MS) treatment,
More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Account Director
-
Excellent benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Account Manager / Account Director
-
Competative
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
New Business Director - PR
-
Competitive Salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
£48, 000 - £60, 000
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
Subscribe to our email news alerts
- Spectral Computed Tomography (CT) Market Global Briefing and Future Outlook 2018 to 2023
- Wearable Heart Monitoring Device Market to Witness Robust Expansion Throughout the Forecast Period 2018 to 2023
- Snoring Control Device Market Global Briefing and Future Outlook 2018 to 2023
- Smart Wellness Market Global Research Analysis 2018 to 2023
- Zinc Lactate Market Overview, Growth Forecast, Demand and Development Research Report to 2023
- Zinc Gluconate Market to Witness Growth Acceleration During 2018-2023
PMHub
GK Strategy
GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
